Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Phase 2

OlaparibOlaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05286827

Conditions

Pancreatic Acinar Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Olaparib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-04-02.